I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
The Acquired Vulnerability Caused by CDK4/6 Inhibition Prom..:
Orawan Suppramote
;
Sunisa Prasopporn
;
Satinee Aroonpruksakul
...
https://www.frontiersin.org/articles/10.3389/fonc.2022.877194/full. , 2022
Link:
https://doi.org/10.3389/fonc.2022.877194
RT Journal T1
The Acquired Vulnerability Caused by CDK4/6 Inhibition Promotes Drug Synergism Between Oxaliplatin and Palbociclib in Cholangiocarcinoma
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:32d7094c80a14ff6b0f96ff7b44b09d6&Exemplar=1&LAN=DE A1 Orawan Suppramote A1 Sunisa Prasopporn A1 Satinee Aroonpruksakul A1 Ben Ponvilawan A1 Jiradej Makjaroen A1 Monthira Suntiparpluacha A1 Krittiya Korphaisarn A1 Komgrid Charngkaew A1 Rawisak Chanwat A1 Trairak Pisitkun A1 Seiji Okada A1 Somponnat Sampattavanich A1 Siwanon Jirawatnotai PB Frontiers Media S.A. YR 2022 K1 acquired vulnerability K1 ribosomal biogenesis stress K1 CDK4/6 inhibitor K1 oxaliplatin K1 cholangiocarcinoma (CCA) K1 palbociclib K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.frontiersin.org/articles/10.3389/fonc.2022.877194/full LK http://dx.doi.org/https://doi.org/10.3389/fonc.2022.877194 DO https://doi.org/10.3389/fonc.2022.877194 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)